Speaking

I speak to boards, leadership teams, and conferences on metabolic health, longevity, and the economics of prevention. If you would like me at your event, start a conversation below.

Keynote Topics Ideas

    The Promise and Pitfalls of GLP-1 Drugs​

    Weight Loss, Genetics, and Precision Metabolic Health

    SYNOPSIS +GLP-1 medications are moving far beyond weight loss and diabetes. Because they act on inflammation and the brain’s reward pathways, they are now being studied in Alzheimer’s, cancer risk and treatment, addiction, and autoimmune conditions like arthritis. In this talk, Dr. Chin moves past the headlines to the precise conversation that matters: how your genetics shape your response, and how bloodwork guides safe, ongoing monitoring, from kidney, liver, and muscle health to lasting behavioral change.
    TAKEAWAYS +
    1. Why genetics shape your response, and why two people on the same drug react differently.
    2. How bloodwork guides safe, ongoing monitoring across kidney, liver, and muscle health.
    3. How GLP-1s work beyond weight loss, through inflammation and the brain’s reward pathways.
    AUDIENCE +Adults considering or already taking GLP-1s, and the employers, benefits advisors, and health leaders supporting them.

    Menopause, the Midlife Metabolic Shift

    Midlife is a metabolic event, not just a hormonal one

    SYNOPSIS +

    Midlife is where metabolism, hormones, and cellular health shift at once, and where women have been most underserved. In this talk, Dr. Chin translates what is happening in perimenopause and menopause, reframing symptoms women are told to tolerate into measurable, treatable biology. She makes the case for ongoing bloodwork and hormone monitoring with saliva testing that matches treatment to symptoms and risk. Care then adjusts across lifestyle, diet, supplements, and, when needed, prescription medication and hormones.

    TAKEAWAYS +
    1. Why the symptoms women are told to tolerate are measurable and treatable.
    2. What the perimenopause to menopause transition does to metabolism, hormones, and cellular health.
    3. How ongoing bloodwork and hormone monitoring match treatment to symptoms and risk.
    AUDIENCE +

    Women 35 to 55, and the employers who want to retain and support them through midlife.

    Metabolic Stress, Not Metabolic Syndrome

    Why High Performers Burn Out Before They Break Down

    SYNOPSIS +

    The people who carry an organization are often its most metabolically depleted, yet no one screens them, because they are assumed to be young and resilient. In this talk, Dr. Chin introduces the distinction between Metabolic Stress, the under fueled, under recovered state of high-output professionals, and Metabolic Syndrome, the familiar cluster of insulin resistance, prediabetes, and obesity. Drawing on the Essential 12 framework and a 12 week corporate pilot program, she reveals why professionals in their peak years can carry the worst metabolic scores in their organization, and what that means for performance and retention.

    TAKEAWAYS +
    1. The difference between Metabolic Stress and Metabolic Syndrome, in plain terms.
    2. Why the people who carry an organization are often the least screened.
    3. What the Essential 12 framework and pilot data reveal about performance and retention.
    AUDIENCE +

    Executives, founders, corporate leadership teams, and the HR and benefits leaders who support their people.

    Recordings

    The Doctor Will See You Now, and By The Way, It’s You